Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 56,333 shares at $11.04 ($689K) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($689k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.04 | 19,608 | $216K | 31.4% |
| 2 | $12.86 | 36,725 | $472K | 68.6% |
| Total | $12.23 avg | 56,333 | $689K | 100% |
| Filing → |
| RGNX | SELL | 2026-03-12 | $53K | — | Filing → |
| RGNX | SELL | 2024-03-07 | $730K | — | Filing → |
| RGNX | SELL | 2024-01-04 | $600K | — | Filing → |